Standard BioTools, Inc. (LAB)
1.055
-0.04
(-3.21%)
USD |
NASDAQ |
May 27, 16:00
1.055
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Cash from Investing (Quarterly) : 191.09M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Rapid Micro Biosystems, Inc. | 8.596M |
| Cytek Biosciences, Inc. | -27.08M |
| Henry Schein, Inc. | -95.00M |
| Accendra Health, Inc. | 53.92M |
| Itonis, Inc. | 0.0014M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -46.60M |
| Cash from Financing (Quarterly) | -0.04M |
| Free Cash Flow | -94.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1215 |
| Free Cash Flow to Equity (Quarterly) | -45.83M |
| Free Cash Flow to Firm (Quarterly) | -47.17M |
| Free Cash Flow Yield | -23.31% |